Index S&P 500
P/E 36.43
EPS (ttm) 4.92
Insider Own 0.07%
Shs Outstand 501.89M
Perf Week -0.60%
Market Cap 82.24B
Forward P/E 29.76
EPS next Y 6.02
Insider Trans -11.26%
Shs Float 458.79M
Perf Month 18.28%
Income 2.28B
PEG 3.49
EPS next Q 1.33
Inst Own 93.70%
Short Float / Ratio 0.66% / 1.64
Perf Quarter -6.96%
Sales 8.37B
P/S 9.82
EPS this Y 10.95%
Inst Trans 0.02%
Short Interest 3.02M
Perf Half Y 4.22%
Book/sh 11.05
P/B 16.21
EPS next Y 11.17%
ROA 16.41%
Target Price 216.96
Perf Year 16.21%
Cash/sh 3.82
P/C 46.89
EPS next 5Y 10.45%
ROE 46.81%
52W Range 140.76 - 194.99
Perf YTD 22.23%
Dividend 1.49
P/FCF 55.12
EPS past 5Y 20.76%
ROI 19.29%
52W High -8.13%
Beta 0.84
Dividend % 0.83%
Quick Ratio 2.16
Sales past 5Y 8.85%
Gross Margin 68.55%
52W Low 27.26%
ATR 3.58
Employees 13800
Current Ratio 3.87
Sales Q/Q 7.44%
Oper. Margin 36.44%
RSI (14) 61.59
Volatility 1.60% 2.19%
Optionable Yes
Debt/Eq 1.33
EPS Q/Q 14.54%
Profit Margin 27.24%
Rel Volume 0.74
Prev Close 176.67
Shortable Yes
LT Debt/Eq 1.33
Earnings Nov 02 BMO
Payout 30.04%
Avg Volume 1.84M
Price 179.13
Recom 1.47
SMA20 3.71%
SMA50 4.71%
SMA200 2.91%
Volume 1,367,199
Change 1.39%
Date
Action
Analyst
Rating Change
Price Target Change
Sep-06-23 Initiated
HSBC Securities
Buy
$230
Jul-12-22 Initiated
Piper Sandler
Overweight
$205
Nov-18-21 Initiated
Morgan Stanley
Overweight
$40
Nov-18-21 Initiated
Morgan Stanley
Overweight
$264
Aug-05-21 Resumed
Credit Suisse
Outperform
$206
Jul-16-21 Downgrade
Raymond James
Outperform → Mkt Perform
Mar-08-21 Upgrade
Raymond James
Mkt Perform → Outperform
$166
Mar-08-21 Upgrade
BofA Securities
Neutral → Buy
$180
Sep-21-20 Initiated
Atlantic Equities
Overweight
$191
Aug-14-20 Upgrade
Edward Jones
Hold → Buy
Aug-12-20 Downgrade
Gabelli & Co
Buy → Hold
May-27-20 Initiated
Jefferies
Buy
$152
Jan-10-20 Initiated
Raymond James
Mkt Perform
Sep-09-19 Initiated
Goldman
Buy
$145
Jul-01-19 Downgrade
BofA/Merrill
Buy → Neutral
$111 → $120
Jun-11-19 Initiated
Barclays
Overweight
$120
May-23-19 Initiated
Guggenheim
Buy
$114
May-03-19 Downgrade
Gabelli & Co
Buy → Hold
$108
Mar-20-19 Initiated
SunTrust
Hold
Mar-04-19 Upgrade
Stifel
Hold → Buy
$97 → $110
Show Previous Ratings
Nov-30-23 02:30PM
Nov-22-23 07:43PM
Nov-21-23 08:30AM
Nov-14-23 06:03AM
Nov-13-23 09:57PM
03:49AM
Loading…
Nov-09-23 03:49AM
Nov-03-23 10:00AM
01:09AM
12:10AM
(Thomson Reuters StreetEvents)
Nov-02-23 05:00PM
03:26PM
02:30PM
12:51PM
12:13PM
08:52AM
08:41AM
Loading…
08:41AM
07:22AM
(Associated Press Finance)
07:00AM
Oct-31-23 10:01AM
Oct-30-23 04:35PM
Oct-27-23 04:28PM
02:23PM
Oct-26-23 11:40AM
10:21AM
10:02AM
Oct-17-23 04:57PM
Oct-12-23 04:15PM
Oct-11-23 06:15AM
Oct-10-23 01:35PM
11:40AM
12:10PM
Loading…
Oct-06-23 12:10PM
Oct-03-23 09:00AM
Sep-27-23 08:37AM
08:30AM
08:00AM
Sep-26-23 12:08PM
Sep-24-23 07:10PM
Sep-20-23 03:00AM
Sep-19-23 01:31PM
Sep-15-23 06:29PM
Sep-13-23 11:40AM
09:55AM
Sep-12-23 05:11PM
06:40AM
Sep-09-23 07:01AM
Sep-07-23 11:30AM
07:45AM
07:00AM
Sep-06-23 04:30PM
Aug-31-23 10:53PM
Aug-30-23 02:07PM
Aug-29-23 06:24PM
Aug-28-23 12:08PM
11:40AM
Aug-25-23 08:44AM
Aug-24-23 02:32PM
Aug-23-23 11:40AM
09:26AM
Aug-22-23 12:37PM
Aug-17-23 03:00PM
Aug-11-23 12:18PM
12:18PM
Aug-10-23 11:40AM
Aug-09-23 06:33PM
02:18PM
(Investor's Business Daily)
11:40AM
Aug-08-23 11:17PM
(Thomson Reuters StreetEvents)
04:09PM
(Investor's Business Daily)
02:30PM
01:58PM
12:37PM
10:48AM
10:30AM
09:20AM
(Investor's Business Daily)
09:16AM
08:15AM
07:16AM
07:00AM
Aug-04-23 01:17PM
Aug-03-23 07:15AM
Aug-01-23 07:57AM
Jul-29-23 09:30AM
Jul-27-23 05:00AM
Jul-26-23 02:17PM
(Investor's Business Daily)
01:39PM
08:30AM
Jul-25-23 04:33PM
(Investor's Business Daily)
03:31PM
03:18PM
(Investor's Business Daily)
Jul-24-23 03:48AM
Jul-23-23 07:31PM
08:00AM
Jul-19-23 05:27AM
Jul-17-23 07:42AM
07:42AM
Jul-16-23 10:00AM
Jul-12-23 08:00AM
08:00AM
Jul-11-23 11:40AM
Jul-10-23 08:00AM
Zoetis, Inc. engages in the discovery, development, manufacture, and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic tests, and precision animal health technology. The firm operates through the United States and International geographical segments. The United States segment is involved in U.S. market and regulatory activities. The International segment includes non-U.S. market and regulatory activities. The company was founded in 1952 and is headquartered in Parsippany, NJ.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
PECK KRISTIN C Chief Executive Officer Nov 21 Option Exercise 46.09 13,000 599,170 69,843 Nov 21 04:41 PM PECK KRISTIN C Chief Executive Officer Nov 21 Sale 176.84 13,000 2,298,856 56,843 Nov 21 04:41 PM Lagano Roxanne Executive Vice President Nov 17 Sale 177.46 923 163,796 22,665 Nov 20 04:45 PM Lagano Roxanne Executive Vice President Oct 18 Sale 172.92 923 159,605 23,588 Oct 19 04:07 PM Lagano Roxanne Executive Vice President Sep 18 Sale 179.58 923 165,752 24,511 Sep 18 04:25 PM Chen Heidi C. Executive Vice President Sep 15 Sale 180.15 9,905 1,784,386 27,478 Sep 18 04:15 PM Lagano Roxanne Executive Vice President Sep 01 Sale 192.97 923 178,111 25,434 Sep 05 05:04 PM PECK KRISTIN C Chief Executive Officer Aug 22 Option Exercise 45.35 13,000 589,585 69,843 Aug 22 04:21 PM PECK KRISTIN C Chief Executive Officer Aug 22 Sale 179.97 13,000 2,339,564 56,843 Aug 22 04:21 PM Polzer Robert J Executive Vice President Aug 09 Option Exercise 144.03 1,179 169,811 3,532 Aug 11 04:32 PM Polzer Robert J Executive Vice President Aug 09 Sale 189.94 1,179 223,939 2,353 Aug 11 04:32 PM PECK KRISTIN C Chief Executive Officer May 23 Option Exercise 41.83 13,000 543,790 69,843 May 25 04:13 PM PECK KRISTIN C Chief Executive Officer May 23 Sale 176.56 13,000 2,295,335 56,843 May 25 04:13 PM Lagano Roxanne Executive Vice President Apr 18 Option Exercise 79.85 4,338 346,398 30,695 Apr 19 04:18 PM Lagano Roxanne Executive Vice President Apr 18 Sale 175.94 4,338 763,228 26,357 Apr 19 04:18 PM Lagano Roxanne Executive Vice President Feb 14 Option Exercise 79.85 13,010 1,038,843 39,367 Feb 16 04:18 PM Lagano Roxanne Executive Vice President Feb 14 Sale 175.00 13,010 2,276,750 26,357 Feb 16 04:18 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite